12:00 AM
 | 
Feb 22, 2000
 |  BC Week In Review  |  Clinical News  |  Clinical Status

2-methoxyestradiol (2ME2): Began Phase I testing

EntreMed Inc. (ENMD), Rockville, Md.
Product: 2-methoxyestradiol ( 2ME2)
Business: Cancer
Therapeutic category:...

Read the full 46 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >